Results 11 to 20 of about 111,076 (331)
Cancers, 2021 Malignant mesothelioma (MM) is a rare and aggressive cancer, related to chronic inflammation and oxidative stress caused mainly by exposure to asbestos [...]
Daniel L. Pouliquen, Joanna Kopecka
openaire +3 more sources
Cancers, 2021 Malignant mesothelioma is a disease affecting serosal surfaces derived from the mesothelium comprising the pleura, peritoneum, pericardium, and tunica vaginalis testis [...]
openaire +2 more sources
BMJ Open Respiratory Research, 2022 Objectives Malignant mesothelioma is an aggressive malignancy of mesothelial surfaces, most commonly those of the pleura. The aim of this study was to understand, using a national questionnaire, the gendered care experiences of patients with malignant ...
Liz Darlison +4 more
doaj +1 more source
EClinicalMedicine, 2022 Summary: Background: Currently, there is no US Food and Drug Administration approved therapy for patients with pleural mesothelioma who have relapsed following platinum-doublet based chemotherapy. Vinorelbine has demonstrated useful clinical activity in
Dean A. Fennell +16 more
doaj +1 more source
Cytojournal, 2022 Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial cavities. It has three variants including: epithelioid, sarcomatous/desmoplastic, and biphasic types. Mesothelioma cells, predominantly of the epithelioid type, can shed into effusions as sheets, clusters/ morulae, papillae, or single cells.
Rao, Nagarjun, Wei, Shuanzeng
openaire +3 more sources
The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
Nature Communications, 2021 Delineation of the genomic complexities of malignant pleural mesothelioma (MPM) has lagged behind other malignancies. Zhang et al. meaningfully add to our understanding of MPM, and their findings emphasize the need to combine drug development efforts ...
Marjorie G. Zauderer
doaj +1 more source
Must countries shoulder the burden of mesothelioma to ban asbestos? A global assessment
BMJ Global Health, 2022 Introduction Mesothelioma is a key asbestos-related disease (ARD) but can be difficult to diagnose. Countries presumably ban asbestos to reduce future ARD burdens, but it is unknown if countries ban asbestos as a consequence of ARD burdens.
Seong-Kyu Kang +10 more
doaj +1 more source
Understanding clinical decision-making in mesothelioma care: a mixed methods study
BMJ Open Respiratory Research, 2022 Introduction Malignant pleural mesothelioma is a rare, incurable cancer arising from previous asbestos exposure; patients have a poor prognosis, with a median survival rate of 8–14 months. Variation in mesothelioma clinical decision-making remains common
Najib Rahman +9 more
doaj +1 more source
Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG
Antioxidants, 2020 The expression of pluripotency factors is a key regulator of tumor differentiation status and cancer stem cells. The purpose of this study was to examine the expression of pluripotency factors and differentiation status of human mesothelioma and the role
Filip Sedlic +8 more
doaj +1 more source
Meet the researchers: an alternative method of engaging patients with research in mesothelioma
Research Involvement and Engagement, 2018 Plain English summary There are new ways to engage people with science and research but many patient support groups and charitable organisations still hold traditional meetings to provide updates on their activities and to report new developments in ...
Kate Hill, Mags Portman, Zsuzsanna Tabi
doaj +1 more source